Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: the PARAGLIDE-HF Trial

Back

HFA Premium Access

Influence of ejection fraction on outcomes with sacubitril/valsartan in patients with worsening heart failure with EF>40%: the PARAGLIDE-HF Trial

Session: Acute heart failure - pharmacotherapy 1

Topic: Pharmacotherapy

Speaker: Doctor A. Peters (Durham, US)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Anthony Peters

Duke University Health System, Durham (United States of America)

0 follower

7 more presentations in this session

COR-1167, a new long-acting CRF2 receptor agonist, decreases congestion by improving cardiorenal function in a sheep model of worsening heart failure (WHF)

Speaker: Doctor P. Janiak (Paris, FR)

The impact of intrarenal venous doppler-guided diuretic management on hospital stay

Speaker: Doctor M. Passos (Amadora, PT)

Mild-to-moderate chronic kidney disease predicts underutilisation of guideline-directed medical therapies in patients with acute heart failure

Speaker: Associate Professor M. Polovina (Belgrade, RS)

Response to up-titration of therapies in patients with new-onset heart failure with and without atrial fibrillation

Speaker: Ms A. Zandijk (Groningen, NL)

Heart failure early post discharge appointment: a 2.5-year single-center experience

Speaker: Doctor M. Passos (Amadora, PT)

Access the full session

Acute heart failure - pharmacotherapy 1

Speakers: Doctor A. Peters, Doctor P. Janiak, Doctor M. Passos, Associate Professor M. Polovina, Ms A. Zandijk...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources